HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasma cell leukemia: a report on three patients.

Abstract
Three patients with plasma cell leukemia are reported. Two of them has a previous history of myeloma; the third one started with a plasma cell leukemia. Diagnosis was made from the required presence of 20% plasma cells in the peripheral blood. In all 3 cases, bone marrow aspiration and peripheral blood showed plasma cells strongly positive for acid phosphatase and alpha-naphthyl acetate esterase, and negative for periodic acid-Schiff. The first patient was treated with a polychemotherapy regimen that included vincristine, cyclophosphamide, chlorambucil and prednisone, and the second patient with melphalan and prednisone; the third one, who started with plasma cell leukemia, received total body irradiation at the dose of 600 rad. The results of the therapy and survival time, which was never more than 3 months, are in accord with other reports in the literature.
AuthorsL Pacilli, P Ferraro, S Cochi, A De Laurenzi
JournalTumori (Tumori) Vol. 69 Issue 6 Pg. 589-91 (Dec 31 1983) ISSN: 0300-8916 [Print] United States
PMID6364515 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Chlorambucil
  • Vincristine
  • Cyclophosphamide
  • Melphalan
  • Prednisone
Topics
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Chlorambucil (administration & dosage)
  • Cyclophosphamide (administration & dosage)
  • Female
  • Humans
  • Leukemia, Plasma Cell (diagnosis, mortality, therapy)
  • Male
  • Melphalan (administration & dosage)
  • Middle Aged
  • Multiple Myeloma (complications)
  • Prednisone (administration & dosage)
  • Time Factors
  • Vincristine (administration & dosage)
  • Whole-Body Irradiation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: